Revolutionizing Transplantation: The Future of Genomics and Molecular Diagnostics in Organ Transplantation

Revolutionizing Transplantation: The Future of Genomics and Molecular Diagnostics - Oct. 19, 2024 - San Diego Marriott

Join us October 19 in La Jolla, California!

This course aspires to identify subject matter experts in multi-organ transplantation to share their insights and knowledge regarding the current and future prospects of genomics and diagnostics in transplantation, providing a comprehensive understanding of this evolving landscape.

Conference Location

San Diego Marriott La Jolla

4240 La Jolla Village Drive

La Jolla, California 92037

Reserve a Discounted Room

Discounts will be available until September 27th

Conference Overview

The landscape of genomics and diagnostics in organ transplantation has witnessed remarkable advancements, undergoing rapid evolution and presenting exciting prospects. These developments hold great promise for enhancing outcomes in transplantation medicine. The primary areas of progress have been in the realms of immunosuppression management, graft surveillance, and the refinement of HLA typing techniques, allowing for more precise donor-recipient matching. Furthermore, emerging techniques have begun to emphasize viral surveillance, recognizing its potential impact on transplantation outcomes, and the monitoring of antibodies, particularly concerning donor-derived cell-free DNA. These innovations collectively contribute to a dynamic and transformative landscape within the field of organ transplantation, offering new avenues to improve patient care and transplantation success.


In addition to the aforementioned technologies, the future holds exciting prospects in the realm of precision medicine, offering highly individualized treatment approaches geared towards minimizing rejection, reducing immunosuppression, and optimizing graft function. The integration of biomarker discovery with artificial intelligence and machine learning promises to unlock the potential for personalized medicine in transplantation. Additionally, there is a growing emphasis on multi-organ preservation techniques, particularly those involving perfusion and preservation, aimed at enhancing the viability of donated organs, thus extending the window of opportunity for transplantation. Regenerative medicine, harnessing the power of stem cells and other innovative techniques, as well as xenotransplantation, are gaining prominence in the field of transplantation. This course aspires to identify subject matter experts in multi-organ transplantation to share their insights and knowledge regarding the current and future prospects of genomics and diagnostics in transplantation, providing a comprehensive understanding of this evolving landscape.

Educational Objectives

After attending this live activity, participants should be able to:

  • Review the rapidly evolving field of genomics and diagnostics in multi-organ transplantation, recognizing its transformative potential in improving patient outcomes.
  • Recognize advanced techniques and strategies for the effective management of immunosuppression in transplant patients, with an emphasis on tailoring treatment to individualized patient profiles.
  • Apply the knowledge from unbiased genomic and diagnostic tools to enhance graft surveillance, early detection of complications, and timely intervention to ensure graft viability and patient well-being.
  • Explore the concept of precision medicine in transplantation, focusing on tailoring treatments to minimize rejection, reduce immunosuppression-related risks, and optimize graft function.
  • Familiarize themselves with advanced organ preservation techniques, including perfusion and preservation methods, aimed at enhancing the viability of donated organs and expanding the transplantation window.
  • Identify subject matter experts in the field of solid organ transplantation who can provide guidance and insights on the current and future prospects of genomics and diagnostics, enabling you to stay at the forefront of the field.
  • Assess current and future prospects of genomics and diagnostics in transplantation, with the aim of staying informed about evolving practices and technologies.
  • Integrate the knowledge and insights gained from this course into everyday practice, effectively utilizing genomics and diagnostics to enhance patient care and transplantation outcomes.

Accreditation and Disclosures

Physicians

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Nurses and Nurse Practitioners

For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.

 

For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit(s)™ for attendance at structured learning activities offered by organizations accredited by the ACCME.

 

The American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

 

Physician Assistants

NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

 

Pharmacists

The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 Credit(s)™.

 

Commercial Support

This course may be supported, in part, by educational grants from industry. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, a complete list of commercial support received will be provided to all learners who participate in the continuing education activity. For more information: www.accme.org/standards.

 

Cultural & Linguistic Competency and Implicit Bias

This activity is designed to include curriculum addressing the topics of cultural and linguistic competency (CLC) and implicit bias (IB) in compliance with California Business and Professions (B&P) Code Section 2190. All those involved in the planning and execution of this activity have been asked to identify and discuss issues relevant to the topics being covered. In addition, a variety of resources are available that address cultural and linguistic competency and implicit bias. A resource document can be downloaded from the Conference Details section above.

Maintenance of Certification

American Board of Internal Medicine

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


American Board of Surgery

Successful completion of this CME activity enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.


American Board of Pathology

Successful completion of this CME activity enables the learner to earn Lifelong Learning (CME) credit toward the CME requirement(s) of the American Board of Pathology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP credit.


MOC points will be awarded to physicians who successfully complete the requirements outlined in the post-activity evaluation. Points earned will be reported to the appropriate specialty board approximately 60 days post conference as long as all learner requirements are met. These credits will not appear on your CME certificate from Scripps.

Attendance and Cancellation Policies

Attendee Cancellation, Substitution, Refund

The course tuition is refundable, minus a $100 processing fee (MD, DO, RN, PA, NP, Other) or a $50 processing fee (Fellow, Resident, Student), if your cancellation is received in writing no later than Friday, October 4, 2024. Attendee substitutions are allowed, but notification must be made in writing by Friday, October 4, 2024. After this date, under no circumstances will refunds, credits, or substitutions be granted. No refunds or credits will be given to “no shows.” No refunds shall be made for cancellations due to inclement weather.

 

Scripps Conference Modification or Cancellation

Scripps reserves the right to modify the course’s schedule or program as necessary. Scripps also reserves the right to cancel this conference, in which case a full refund of the registration fee will be provided. Attendees who purchase non-refundable airline tickets do so at their own risk. Scripps encourages the purchase of travel insurance as we are unable to refund any travel costs (flight, hotel, etc.) in the case of Scripps cancellation.

 

Health and Safety Waiver and Assumption of Risk

By completion and submission of the online registration form, attendees certify they have read and fully understand the Health and Safety Waiver and Assumption of Risk Agreement.

 

Family and Guest Attendance Policy

All conference activities and meals are exclusively reserved for paid conference attendees. Children and family members are not allowed to attend meal functions or permitted in the meeting space.

 

Recording and Photography Clause

Scripps reserves exclusive rights to record (audio and video) and/or photograph all conference proceedings for use in marketing materials, presentations and course content sales.

Event details

Location
San Diego Marriott La Jolla

4240 La Jolla Village Drive
La Jolla, CA 92037
Get directions
Date and time

Sat, Oct 19, 2024

7 am - 5 pm PDT

Fee
$300.00